About Us
Our Vision & Mission
Eazebio is a precision health company advancing the future of diagnostics and preventive care. We're building a biomarker-powered platform to detect health challenges earlier and intervene smarter -- from autoimmune to metabolic and hormonal disorders. Our approach combines scientific rigor, personal lived experience, and strong IP to clise the gap between data and healing.
At Eazebio, we're not just measuring health -- we're making it more human.
Our Expertise
With a team of experienced medical research professionals, EAZE BIO specializes in translating scientific breakthroughs into practical applications. Our expertise spans various therapeutic areas, ensuring that we meet the diverse needs of the healthcare industry, especially for women.
Research Initiatives
At EAZE BIO, we are dedicated to engaging in diverse research initiatives focusing on critical areas such as point-of-care diagnostic tools and therapeutics. Our goal is to make a significant contribution to the scientific community and to develop therapies that improve the quality of life for patients worldwide.
Our Team
Reem Mahrat - Founder/CEO
Ying Chen, Ph.D., MBA candidate - Co-Founder/CTO
Janelle Muranaka - Co-Founder/COO
• 23+ years in biopharma industry
• Successful exits scaling impactful ventures
- Raman ID acquired by NOMADX Holdings, 2024
- Calico Biolabs acquired by Abcam, 2019
• Experienced founder at 4 prior companies
• Healthcare innovator delivering transformative point-of-care and diagnostic solutions
Janelle Muranaka - Co-Founder/COO
Ying Chen, Ph.D., MBA candidate - Co-Founder/CTO
Janelle Muranaka - Co-Founder/COO
• 16+ years in biotech industry
• Proven record scaling biotech startups from seed funding through clinical development
• Employee #2-3 at three prior biotech startups
• Co-founder of Maxygen LLC
• Expertise in cell & molecular biology, vaccine development, and protein engineering
Aditi Malu, Ph.D. - Co-Founder/CSO
Ying Chen, Ph.D., MBA candidate - Co-Founder/CTO
Ying Chen, Ph.D., MBA candidate - Co-Founder/CTO
• 15 years in biological research
• Leads innovation and research at EazeBio
• Translational biology expert generating technical strategies and R&D development plans
Ying Chen, Ph.D., MBA candidate - Co-Founder/CTO
Ying Chen, Ph.D., MBA candidate - Co-Founder/CTO
Ying Chen, Ph.D., MBA candidate - Co-Founder/CTO
• 12+ years in biotech & academic settings
• Published 10+ peer-reviewed articles
• Overseen 1000s of CRISPR gene-editing projects
• Expertise in global cross-team leadership and strategic problem solving
• Medical educator
Bill Howell, M.D., Ph.D. - CMO
Bill Howell, M.D., Ph.D. - CMO
Bill Howell, M.D., Ph.D. - CMO
• Physician-scientist trained in anatomic, clinical, and molecular genetic pathology at Stanford University
• CMO at RamanID, successful exit in 2024
• CMO roles at Tackle Bio (current) and TheraSentient BioPharma (previous)
Meryem Rqibate, M.D., MBA
Bill Howell, M.D., Ph.D. - CMO
Bill Howell, M.D., Ph.D. - CMO
• Conducted clinical research for C-section risk on scarred uterine tissue
• Certificates in Medical Statistics & Python Programming to navigate the intersection of medicine, data science, & biotech innovation
• Director of Operations at Daybreak Labs
Geeta Kutty, M.D.
Bill Howell, M.D., Ph.D. - CMO
Geeta Kutty, M.D.
• A board-certified gastroenterologist and Medical Director at San Jose Gastroenterology
• Integrate AI and health technology to streamline clinical workflows and enhance patient outcomes
• Committed to pushing the boundaries of digestive health through technology, research, and public speaking engagements, inspiring the next generation of healthcare solutions
Isam Alyousfi
Bill Howell, M.D., Ph.D. - CMO
Geeta Kutty, M.D.
• A technology executive with over 30 years of experience driving innovation in analytics, artificial intelligence, and data strategy
• Recognized for leading high-impact digital transformations, building world-class teams, and delivering cutting-edge solutions across global enterprises
• Passionate about harnessing data to unlock
• A technology executive with over 30 years of experience driving innovation in analytics, artificial intelligence, and data strategy
• Recognized for leading high-impact digital transformations, building world-class teams, and delivering cutting-edge solutions across global enterprises
• Passionate about harnessing data to unlock business value, with a proven track record of scaling emerging technologies and shaping forward-thinking strategies in dynamic, fast-paced environments
Akshiv Malhotra, M.D.
Vinod Reddy Lekkala, Ph.D.
Jordan R. Plews, Ph.D.
• Board-certified medical oncologist at UCSF Health
• Expertise in gastrointestinal cancers, including pancreatic, colorectal, gastric, and esophageal cancers
• Focus on patient care, disease prevention, and healthcare accessibility
Jordan R. Plews, Ph.D.
Vinod Reddy Lekkala, Ph.D.
Jordan R. Plews, Ph.D.
• An innovator and expert in stem cell biology, regenerative medicine, and biochemical engineering.
• Research contributed to major advances in cellular reprogramming and induced pluripotency.
• Co-founded companies at the interface of science, medicine, and aesthetics.
• Co-founder of Xytogen Biotech and ELEVAI Labs Inc., two pio
• An innovator and expert in stem cell biology, regenerative medicine, and biochemical engineering.
• Research contributed to major advances in cellular reprogramming and induced pluripotency.
• Co-founded companies at the interface of science, medicine, and aesthetics.
• Co-founder of Xytogen Biotech and ELEVAI Labs Inc., two pioneering companies in the cosmeceutical and regenerative skincare space.
• Led the development of a portfolio of exosome-based skin and haircare products that brought advanced stem cell science to medical aesthetics.
• Developed and launched more than 20 products, translating cutting-edge stem cell research, regenerative medicine, genomics, and longevity science into commercially successful innovations.
• Published his research in respected journals such as Nature Methods, the Journal of Cellular and Molecular Medicine, and Stem Cell Research & Therapy.
Vinod Reddy Lekkala, Ph.D.
Vinod Reddy Lekkala, Ph.D.
Vinod Reddy Lekkala, Ph.D.
• Advanced degrees in biotechnology and stem cells for tissue regeneration
• Technical expertise in organoid development, stem cell biology, CRISPR, and cell engineering technologies
Postdoctoral Researcher at UCSF
Dr. Bassam El Fahmawi
Vinod Reddy Lekkala, Ph.D.
Vinod Reddy Lekkala, Ph.D.
• Invented iSWAB for swab-based collection, and HemaSure-OMICs, a direct draw-tube for whole blood multi-omics analysis.
• Founder and CTO of Mawi DNA Technologies, a growth-stage company working at the front lines of the COVID-19 battle.
• More than 25 years of experience in the genomics sample preparation market.
• Led nucleic ac
• Invented iSWAB for swab-based collection, and HemaSure-OMICs, a direct draw-tube for whole blood multi-omics analysis.
• Founder and CTO of Mawi DNA Technologies, a growth-stage company working at the front lines of the COVID-19 battle.
• More than 25 years of experience in the genomics sample preparation market.
• Led nucleic acid purification technologies commercialization at both Beckman Coulter Genomics (formerly Agencourt) and Corning.
• Published several patents for simplifying nucleic acid purification and sample collection.